Eli Lilly to buy Ajax Therapeutics
Beyond the Blockbusters: The Strategic Shift in Oncology Pipelines The pharmaceutical landscape is witnessing a pivotal shift. Even as weight-loss medications have captured global headlines, industry giants are quietly reinforcing their foundations in oncology. A prime example is Eli Lilly and Company’s recent move to acquire Ajax Therapeutics for up to $2.3 billion in cash. … Read more